Showing results (371-380 of 835) with videos related to

Sort By:
Pageof 84
Journal of Clinical Hypertension (Greenwich, Conn.)|January 9, 2009
Management of high blood pressure in clinical practice: perceptible qualitative differences in approaches utilized by cliniciansChuke E Nwachuku, Arnaud Bastien, Jeffrey A Cutler, et al.
The Lancet. Oncology|April 1, 2021
Antihypertensive treatment and risk of cancer: an individual participant data meta-analysisEmma Copland, Dexter Canoy, Milad Nazarzadeh, et al.
Fish & Shellfish Immunology|June 18, 2022
A short peptidoglycan recognition protein protects Boleophthalmus pectinirostris against bacterial infection via inhibiting bacterial activitySheng Luo, Li-Cong Wang, Zhi-Han Shuai, et al.
Movement Disorders Clinical Practice|October 11, 2021
Novel Approach to Movement Disorder Society-Unified Parkinson's Disease Rating Scale Monitoring in Clinical Trials: Longitudinal Item Response Theory ModelsSheng Luo, Haotian Zou, Christopher G Goetz, et al.
World Journal of Gastroenterology|January 20, 2011
LY294002 potentiates the anti-cancer effect of oxaliplatin for gastric cancer via death receptor pathwayJie Liu, Xue-Qiong Fu, Wei Zhou, et al.
Cancer Innovation|February 2, 2026
AI and Big Data in Oncology: A Physician-Centered Perspective on Emerging Clinical and Research ApplicationsBinliang Liu, Qingyao Shang, Jun Li, et al.
Academic Radiology|December 2, 2019
Generalized Linear Binning to Compare Hyperpolarized 129Xe Ventilation Maps Derived from 3D Radial Gas Exchange Versus Dedicated Multislice Gradient Echo MRIMu He, Ziyi Wang, Leith Rankine, et al.
Journal of Agricultural and Food Chemistry|March 26, 2019
Assessment of Multiorigin Humin Components Evolution and Influencing Factors During CompostingXinyu Xie, Xintong Gao, Chaonan Pan, et al.
Molecular Carcinogenesis|May 6, 2020
Genetic variants of the peroxisome proliferator-activated receptor (PPAR) signaling pathway genes and risk of pancreatic cancerXiaowen Liu, Danwen Qian, Hongliang Liu, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|September 1, 2006
Thalidomide in rat liver cirrhosis: blockade of tumor necrosis factor-alpha via inhibition of degradation of an inhibitor of nuclear factor-kappaBShelley Chireyath Paul, Peng Lv, Yan-Jv Xiao, et al.
Pageof 84